Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

510 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.
Witthuhn BA, Williams MD, Kerawalla H, Uckun FM. Witthuhn BA, et al. Among authors: uckun fm. Leuk Lymphoma. 1999 Jan;32(3-4):289-97. doi: 10.3109/10428199909167389. Leuk Lymphoma. 1999. PMID: 10037026
Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia.
Wood CM, Goodman PA, Uckun FM. Wood CM, et al. Among authors: uckun fm. Leuk Lymphoma. 2002 Dec;43(12):2355-62. doi: 10.1080/1042819021000040062. Leuk Lymphoma. 2002. PMID: 12613524
Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
Goodman PA, Burkhardt N, Juran B, Tibbles HE, Uckun FM. Goodman PA, et al. Among authors: uckun fm. Oncogene. 2003 Apr 24;22(16):2504-14. doi: 10.1038/sj.onc.1206313. Oncogene. 2003. PMID: 12717427
Use of Lymphoid Progenitor Cell Assays for a More Detailed Analysis of the Cytogenetic Changes Occurring During Clonal Evolution in Acute Lymphoblastic Leukemia.
Uckun FM, Heerema NA. Uckun FM, et al. Leuk Lymphoma. 1990;2(1-2):1-16. doi: 10.3109/10428199009042510. Leuk Lymphoma. 1990. PMID: 27456567
Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me2-Phen)2] depolarizes mitochondrial membranes.
Narla RK, Dong Y, Uckun FM. Narla RK, et al. Among authors: uckun fm. Leuk Lymphoma. 2001 May;41(5-6):625-34. doi: 10.3109/10428190109060353. Leuk Lymphoma. 2001. PMID: 11378580
Histamine as an autocrine regulator of leukemic cell proliferation.
Malaviya R, Uckun FM. Malaviya R, et al. Among authors: uckun fm. Leuk Lymphoma. 2000 Jan;36(3-4):367-73. doi: 10.3109/10428190009148858. Leuk Lymphoma. 2000. PMID: 10674909
Evaluation of temozolomide in a SCID mouse model of human B-cell precursor leukemia.
Messinger Y, Reaman GH, Ek O, Uckun FM. Messinger Y, et al. Among authors: uckun fm. Leuk Lymphoma. 1999 Apr;33(3-4):289-93. doi: 10.3109/10428199909058428. Leuk Lymphoma. 1999. PMID: 10221508
In vitro and in vivo anti-leukemic efficacy of cyclic AMP modulating agents against human leukemic B-cell precursors.
Myers DE, Chandan-Langlie M, Chelstrom LM, Uckun FM. Myers DE, et al. Among authors: uckun fm. Leuk Lymphoma. 1996 Jul;22(3-4):259-64. doi: 10.3109/10428199609051756. Leuk Lymphoma. 1996. PMID: 8819074
Role of tyrosine phosphorylation in radiation-induced cell cycle-arrest of leukemic B-cell precursors at the G2-M transition checkpoint.
Tuel-Ahlgren L, Jun X, Waddick KG, Jin J, Bolen J, Uckun FM. Tuel-Ahlgren L, et al. Among authors: uckun fm. Leuk Lymphoma. 1996 Feb;20(5-6):417-26. doi: 10.3109/10428199609052423. Leuk Lymphoma. 1996. PMID: 8833397
Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials.
Myers DE, Jun X, Clementson D, Donelson R, Sicheneder A, Hoffman N, Bell K, Sarquis M, Langlie MC, Turner N, Uckun FM. Myers DE, et al. Among authors: uckun fm. Leuk Lymphoma. 1997 Oct;27(3-4):275-302. doi: 10.3109/10428199709059683. Leuk Lymphoma. 1997. PMID: 9402326 Review.
510 results
Jump to page